Research letter: Pilot study of a prototype fully automated mass spectrometry system for routine clinical laboratory use
including Cobas i601 analytical unit and Ionify reagent line) is in development, not approved by regulatory bodies, and not commercially available.COBAS and IONIFY are trademarks of Roche.
Authors
- Christian Schneider-Thauern
- Michael Vogeser (ORCID: https://orcid.org/0000-0002-2745-2475)
- Katharina Habler (ORCID: https://orcid.org/0000-0002-5110-346X)
- Antje Reuter
Institutions
- LMU Klinikum (DE)
- Roche Pharma AG (Germany) (DE)
- CS Diagnostics (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of Mass Spectrometry and Advances in the Clinical Lab
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1016/j.jmsacl.2024.10.004
- Citations
- 9
- Primary Topic
- Mass Spectrometry Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 2.17
Funders
- Roche